Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionaleng
dc.contributor.authorChang, Aileen Y.
dc.contributor.authorLynch, Rebecca
dc.contributor.authorMartins, Karen
dc.contributor.authorEncinales, Liliana
dc.contributor.authorCadena Bonfanti, Andrés Á.
dc.contributor.authorPacheco, Nelly
dc.contributor.authorReid, St. Patrick
dc.contributor.authorLara Sarabia, Osvaldo E.
dc.contributor.authorGonzález Torres, Henry J.
dc.contributor.authorMejia Castillo, Stella
dc.contributor.authorBarrios Taborda, Onaldo
dc.contributor.authorAlarcon Gomez, Magda
dc.contributor.authorGuerra Duran, Brenda
dc.contributor.authorMartinez Giraldo, Victor
dc.contributor.authorBenitez Ospino, Angélica
dc.contributor.authorPorras, Alexandra
dc.contributor.authorMendoza, Alejandro R.
dc.contributor.authorMantus, Grace
dc.contributor.authorLi, Guangzhao
dc.contributor.authorPeng, Jin
dc.contributor.authorKamalapathy, Priyanka
dc.contributor.authorAvendaño Echavez, Lil G.
dc.contributor.authorDowd, Kimberly A.
dc.contributor.authorRengifo-Pardo, Monica
dc.contributor.authorBarraza, Pedro Pablo
dc.contributor.authorJiménez Hernàndez, Dennys
dc.contributor.authorGonzález Coba, Andrés
dc.contributor.authorDe La Hoz Mendoza, Katya
dc.contributor.authorBethony, Jeffrey M.
dc.contributor.authorSimon, Gary L.
dc.description.abstractZika virus infection has been associated with the development of a spectrum of neurologic disease including Guillain–Barré syndrome (GBS)1. GBS is an autoimmune disorder of the peripheral nervous system often triggered by a preceding infection. The mechanism of Zika-associated GBS (Z-GBS) and the long-term clinical course is unknown. The purpose of this study was to describe the 2-year clinical course of Z-GBS in order to provide further insights into disease pathogenesis and prognosis.eng
dc.sourceEmerging Microbes & Infectionseng
dc.sourceVol. 7, No.148 (2018)eng
dc.subjectGuillain-Barre Syndromeeng
dc.subjectChinkungunya infectioneng
dc.subjectInfectious disease controleng
dc.subjectRespiratory infectionseng
dc.titleLong-term clinical outcomes of Zikaassociated Guillain-Barré syndromeeng
dcterms.referencesParra, B. et al. Guillain–Barré syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375, 1513–1523 (2016).eng
dcterms.referencesHughes, R. A. et al. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 130, 2245–2257 (2007).eng
dcterms.referencesRees, J. H., Soudain, S. E., Gregson, N. A. & Hughes, R. A. Campylobacter jejuni infection and Guillain–Barré syndrome. N. Engl. J. Med. 333, 1374–1379 (1995).eng
dcterms.referencesIslam, B. et al. Guillain-Barré syndrome following varicella-zoster virus infection. Eur. J. Clin. Microbiol Infect. Dis. 37, 511–518 (2018).eng
dcterms.referencesCao-Lormeau, V. et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 10027, 1531–1539 (2016).eng
dcterms.referencesArias, A. et al. Guillain-Barré syndrome in patients with a recent history of Zika in Cucuta, Colombia: a descriptive case series of 19 patients from December 2015 to March 2016. J. Crit. Care. 37, 19–23 (2017).eng
dcterms.referencesAnaya, J. et al. A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia. J. Autoimmun. 77, 123–138 (2017).eng
dcterms.referencesHughes, R. A. & Cornblath, D. R. Guillain-Barre syndrome. Lancet 366, 1653–1666 (2005).eng
dcterms.referencesGriffin, J. et al. Pathology of the motor‐sensory axonal Guillain‐Barré syndrome. Ann. Neurol. 39, 17–28 (1996).eng
dcterms.referencesSejvar, J. J. et al. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29, 599–612 (2011).eng
dcterms.referencesDowd, K. A. et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 16, 1485–1491 (2016).eng
dcterms.referencesFrenzen, P. D. Economic cost of Guillain-Barre syndrome in the United States. Neurology 71, 21–27 (2008).eng
dcterms.referencesWolfe, F., Michaud, K. & Pincus, T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheumatol. 50, 3296–3305 (2004).eng

Ficheros en el ítem


Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem